Analysts Set Dolby Laboratories (NYSE:DLB) PT at $95.75

Dolby Laboratories (NYSE:DLB) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $95.75.

DLB has been the topic of a number of research reports. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, September 12th. Robert W. Baird assumed coverage on Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price objective for the company. Tigress Financial increased their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $95.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 1st.

Dolby Laboratories Stock Performance

DLB stock opened at $66.64 on Friday. The stock’s 50 day simple moving average is $71.13 and its 200 day simple moving average is $73.43. Dolby Laboratories has a fifty-two week low of $66.52 and a fifty-two week high of $89.66. The company has a market cap of $6.39 billion, a P/E ratio of 24.41 and a beta of 0.92.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. During the same period in the prior year, the business earned $0.71 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Equities analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were paid a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 annualized dividend and a dividend yield of 2.0%. Dolby Laboratories’s dividend payout ratio is 48.35%.

Insider Activity at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction that occurred on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 82,000 shares of company stock valued at $5,845,440. Company insiders own 38.39% of the company’s stock.

Institutional Trading of Dolby Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of the business. Evergreen Capital Management LLC purchased a new stake in shares of Dolby Laboratories during the third quarter valued at approximately $326,000. Diversified Investment Strategies LLC increased its position in shares of Dolby Laboratories by 0.5% during the third quarter. Diversified Investment Strategies LLC now owns 59,145 shares of the electronics maker’s stock valued at $4,280,000 after acquiring an additional 300 shares during the last quarter. First Horizon Corp purchased a new stake in shares of Dolby Laboratories during the third quarter valued at approximately $25,000. Meeder Asset Management Inc. increased its position in shares of Dolby Laboratories by 787.1% during the third quarter. Meeder Asset Management Inc. now owns 27,526 shares of the electronics maker’s stock valued at $1,992,000 after acquiring an additional 24,423 shares during the last quarter. Finally, Summit Creek Advisors LLC increased its position in shares of Dolby Laboratories by 24.9% during the third quarter. Summit Creek Advisors LLC now owns 125,034 shares of the electronics maker’s stock valued at $9,049,000 after acquiring an additional 24,905 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.